HIV - HUMAN IMMUNODEFICIENCY VIRUS
Clinical trials for HIV - HUMAN IMMUNODEFICIENCY VIRUS explained in plain language.
Never miss a new study
Get alerted when new HIV - HUMAN IMMUNODEFICIENCY VIRUS trials appear
Sign up with your email to follow new studies for HIV - HUMAN IMMUNODEFICIENCY VIRUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New program aims to boost HIV care for transgender women in vietnam
Disease control Recruiting nowThis study tests a program to help transgender women in Ho Chi Minh City improve their HIV prevention and care. Participants will attend counseling sessions, skill-building groups, and social events. The goal is to see if this support helps them stay healthy, whether they are HIV…
Matched conditions: HIV - HUMAN IMMUNODEFICIENCY VIRUS
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated May 16, 2026 22:28 UTC
-
Cash after jail: a new way to fight HIV?
Disease control Recruiting nowThis study tests whether giving guaranteed income to people with HIV recently released from jail helps them stay in HIV care and keep the virus under control. 33 participants will receive money as a lump sum, monthly payments, or choose their preference. Researchers will measure …
Matched conditions: HIV - HUMAN IMMUNODEFICIENCY VIRUS
Phase: NA • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated May 16, 2026 22:28 UTC
-
New antibody combo aims to flush out hidden HIV
Disease control Recruiting nowThis early-stage study tests whether two experimental antibodies (MGD014 and MGD020) are safe in people with HIV who are on standard antiretroviral therapy. Some participants also receive a drug called Vorinostat to help expose hidden HIV, or temporarily stop their HIV meds. The …
Matched conditions: HIV - HUMAN IMMUNODEFICIENCY VIRUS
Phase: PHASE1 • Sponsor: University of North Carolina, Chapel Hill • Aim: Disease control
Last updated May 16, 2026 22:28 UTC
-
Could a diabetes pill fight HIV-related obesity?
Disease control Recruiting nowThis study tests whether empagliflozin, a diabetes drug, can help people with HIV who are overweight or obese lose weight and improve their metabolism. About 66 adults with HIV on a specific antiretroviral therapy will receive either the drug or a placebo for 6 months. The main g…
Matched conditions: HIV - HUMAN IMMUNODEFICIENCY VIRUS
Phase: PHASE2 • Sponsor: Abdelrahman Mahmoud • Aim: Disease control
Last updated May 15, 2026 12:07 UTC
-
Could a new drug shrink fatty livers in people with HIV?
Disease control Recruiting nowThis study tests whether resmetirom, a drug already approved for other liver conditions, can safely reduce liver fat in people with HIV who also have a fatty liver disease called MASLD. About 120 adults will take either the drug or a placebo daily for 24 weeks. Researchers will m…
Matched conditions: HIV - HUMAN IMMUNODEFICIENCY VIRUS
Phase: PHASE2 • Sponsor: Naga P. Chalasani • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Hair analysis could reveal hidden HIV pill skipping
Diagnosis Recruiting nowThis study explores whether a strand of hair can reliably measure levels of two common HIV drugs (emtricitabine and lamivudine) to detect when patients miss doses. Researchers will enroll 30 people with HIV who are currently taking these medications and have good adherence. By co…
Matched conditions: HIV - HUMAN IMMUNODEFICIENCY VIRUS
Sponsor: University Hospital, Toulouse • Aim: Diagnosis
Last updated May 16, 2026 22:33 UTC
-
HIV prevention pills offered alongside opioid therapy in pharmacies
Prevention Recruiting nowThis study looks at whether giving HIV prevention pills (PrEP) at the same time as opioid addiction treatment in pharmacies is practical and well-liked. About 350 HIV-negative people at risk for HIV who are already in an opioid treatment program will take part. Researchers will t…
Matched conditions: HIV - HUMAN IMMUNODEFICIENCY VIRUS
Phase: PHASE4 • Sponsor: Cara Spence • Aim: Prevention
Last updated May 15, 2026 11:54 UTC
-
New program aims to tackle HIV stigma and mental health struggles in zambian youth
Knowledge-focused Recruiting nowThis study tests a new program called Project YES+ for youth aged 15-21 living with HIV in Zambia. The program combines peer mentoring with a mental health approach endorsed by the World Health Organization to reduce stigma related to HIV, violence, and mental health. Researchers…
Matched conditions: HIV - HUMAN IMMUNODEFICIENCY VIRUS
Phase: NA • Sponsor: Johns Hopkins Bloomberg School of Public Health • Aim: Knowledge-focused
Last updated May 15, 2026 11:53 UTC
-
Village healers take on HIV testing for kids
Knowledge-focused Recruiting nowThis study looks at whether traditional healers in rural Uganda can offer HIV tests to children aged 18 months to 5 years. Researchers want to see if parents accept testing from a healer versus being referred to a clinic. About 400 children will take part, and the goal is to find…
Matched conditions: HIV - HUMAN IMMUNODEFICIENCY VIRUS
Phase: NA • Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated May 14, 2026 12:05 UTC
-
Silent spreaders? new study investigates asymptomatic TB transmission
Knowledge-focused Recruiting nowThis study looks at whether people with tuberculosis (TB) who have no symptoms can still pass the infection to others. Researchers will track about 6,770 participants, including those with HIV, using advanced genetic tools to see if asymptomatic TB cases cause new infections. The…
Matched conditions: HIV - HUMAN IMMUNODEFICIENCY VIRUS
Sponsor: Barcelona Institute for Global Health • Aim: Knowledge-focused
Last updated May 06, 2026 16:15 UTC